Strata Critical Medical (SRTA) Treasury Shares (2019 - 2021)

Strata Critical Medical (SRTA) has reported Treasury Shares for 8 consecutive years, with $13.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares rose 24.61% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 24.61% YoY), while the FY2025 annual figure was $9.7 million, up 4.95% from the prior year.
• Treasury Shares grew to $13.6 million in Q1 2026 per SRTA's latest filing, from $9.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $13.6 million in Q1 2026 and bottomed at $2.4 million in Q3 2022.
• Historically, Treasury Shares has averaged $8.1 million across 5 years, with a median of $9.3 million in 2024.
• On a YoY basis, Treasury Shares climbed as much as 243.54% in 2022 and fell as far as 88.93% in 2022.
• Strata Critical Medical's Treasury Shares stood at $7.5 million in 2022, then decreased by 29.55% to $5.3 million in 2023, then surged by 76.54% to $9.3 million in 2024, then gained by 4.95% to $9.7 million in 2025, then jumped by 39.11% to $13.6 million in 2026.
• Business Quant data shows SRTA's Treasury Shares at $13.6 million in Q1 2026, $9.7 million in Q4 2025, and $10.4 million in Q3 2025.